title: The parasympathetic nervous system and the thermic effect of glucose/insulin infusions in humans.
abstract: The thermic effect of glucose/insulin infusions was investigated in seven healthy young men before and during either inhibition (atropine sulphate 10 micrograms/kg bolus; 10 micrograms/kg/h) or stimulation (edrophonium chloride, 10 mg bolus; 0.75 mg/min starting rate) of the parasympathetic nervous system. The thermic effects of glucose/insulin were 6.2% +/- 0.4% and 5.6% +/- 0.7% before atropine and edrophonium, respectively, and increased to 7.1% +/- 0.5% (NS) with atropine and 7.5% +/- 1.2% (P less than .05) with edrophonium. In four subjects atropine or edrophonium was infused before the hyperinsulinemic, euglycemic clamp. A significant increase in resting metabolic rate and plasma norepinephrine concentrations was observed with edrophonium alone. When the thermic effects of glucose/insulin were calculated with respect to the metabolic rates observed during the drug infusions alone, they were 5.9% +/- 1.4% and 3.6% +/- 0.6% (NS) for the clamp + atropine and clamp + edrophonium, respectively. These results demonstrate that the increases in the thermic effect of glucose/insulin infusions observed during inhibition or stimulation of the parasympathetic nervous system were due to atropine or edrophonium increasing the resting metabolic rate rather than increasing the thermic response to glucose-insulin infusions. However, because it has been shown that atropine can decrease the thermic effect of an orally administered meal by approximately 60%, it would appear that the parasympathetic nervous system can influence the thermic effect of food by affecting the rate of digestion, absorption and storage of the ingested nutrients.
authors.affiliation: Department of Anesthesiology, University Lausanne, Switzerland.
authors.forename: O
authors.initials: O
authors.lastname: Dériaz
authors.forename: C A
authors.initials: CA
authors.lastname: Nacht
authors.forename: R
authors.initials: R
authors.lastname: Chioléro
authors.forename: E
authors.initials: E
authors.lastname: Jéquier
authors.forename: K J
authors.initials: KJ
authors.lastname: Acheson
mesh_terms: D000328:Adult; D001285:Atropine / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects*; D004491:Edrophonium / Q000494:pharmacology; D004734:Energy Metabolism / Q000187:drug effects; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006706:Homeostasis; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D009407:Nerve Block; D009638:Norepinephrine / Q000097:blood; D009994:Osmolar Concentration; D010275:Parasympathetic Nervous System / Q000502:physiology*; D012146:Rest
chemical_list: D007328:Insulin; D004491:Edrophonium; D001285:Atropine; D005947:Glucose; D009638:Norepinephrine